Pediatrix Medical Group, Inc.
corporate_fare Company Profile
Pediatrix Medical Group, Inc. (NYSE:MD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for MD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-04, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for MD spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Pediatrix Q2 2026: Adjusted EPS $0.63 Beats Estimates, Full-Year EBITDA Guidance Reaffirmed
- Pediatrix Q2 Earnings Beat with $0.63 Adjusted EPS; Reaffirms 2026 EBITDA Guidance
- Pediatrix Medical Posts 63c Adj EPS in Q2, Topping Expectations
- Pediatrix Reaffirms $280M–$300M EBITDA Outlook, Dismisses Sector Headwinds
- Shareholders Approve 8 Million New Shares for Incentive Plan, Signaling Potential Dilution
Financial Snapshot
Short Interest & Short Volume
6.90 days to coverFINRA reported short interest of 4,730,174 shares in MD as of the September 15, 2026 settlement, a 1.8% decrease from the prior period — about 6.9 days to cover at its recent average daily volume. On October 2, 2026, 76.3% of MD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.